Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Skin and mucosal issues can occur after COVID-19 in adults and children.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Olive oil can help regrow hair lost due to COVID-19 or vaccination.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Higher androgen levels might make COVID-19 worse, especially in men.

Women with high androgen levels may have more severe COVID-19 symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

COVID-19 may cause temporary hair loss in some people.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

COVID-19 may cause increased and quicker hair loss compared to other infections.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.

Hair loss link to COVID-19 severity likely due to other factors.

Cepharanthine could be a strong antiviral against COVID-19.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.